---
title: "Ross Lorberbaum of Paragon is named to ANS Nuclear News \"40 Under 40\" list. Honors rising stars in nuclear community."
type: "News"
locale: "en"
url: "https://longbridge.com/en/news/264269716.md"
description: "In Fort Worth, Texas on November 4, 2025, Ross Lorberbaum, Vice President of CoreVision at Paragon, has been selected for the \"40 Under 40\" list by the American Nuclear Society's (ANS) Nuclear News. This prestigious list acknowledges promising individuals from the nuclear sector. Lorberbaum's outstanding contributions led to his recognition."
datetime: "2025-11-04T17:34:36.000Z"
locales:
  - [zh-CN](https://longbridge.com/zh-CN/news/264269716.md)
  - [en](https://longbridge.com/en/news/264269716.md)
  - [zh-HK](https://longbridge.com/zh-HK/news/264269716.md)
generator: "portal-rs"
---

# Ross Lorberbaum of Paragon is named to ANS Nuclear News "40 Under 40" list. Honors rising stars in nuclear community.

In Fort Worth, Texas on November 4, 2025, Ross Lorberbaum, Vice President of CoreVision at Paragon, has been selected for the "40 Under 40" list by the American Nuclear Society's (ANS) Nuclear News. This prestigious list acknowledges promising individuals from the nuclear sector. Lorberbaum's outstanding contributions led to his recognition.

### Related Stocks

- [FNA.US](https://longbridge.com/en/quote/FNA.US.md)

## Related News & Research

- [Oil set for second weekly rise as unsettled US-Iran war crimps supply](https://longbridge.com/en/news/296555193.md)
- [IREN Just Passed Its Biggest AI Test as Microsoft and Nvidia Bet Billions](https://longbridge.com/en/news/296533962.md)
- [Trump Boosted INTC and DELL: Now He Says ‘Do Magnets’—Are MP and USAR Stocks Next?](https://longbridge.com/en/news/296591886.md)
- [Why Iovance Biotherapeutics Stock Hit 52-Week High](https://longbridge.com/en/news/296522969.md)
- [Broadcom Stabilizes After Google's $120 Billion Marvell Shock](https://longbridge.com/en/news/296529317.md)

---
> **Disclaimer: This article is for reference only and does not constitute any investment advice.**